Streetbeat News

Regulatory

AVGO

DLTR

NVDA

SAIC

TTC

The S&P 500 and Nasdaq fell for the second consecutive session, influenced by Nvidia's decline due to a DOJ subpoena and Dollar Tree's poor earnings. The Fear & Greed Index is in the 'Neutral' zone, reflecting mixed market sentiment.

Portfolio Pulse from Avi Kapoor

September 05, 2024 | 6:55 am

NUVO

The U.S. Bankruptcy Court for the District of Delaware has imposed significant trading restrictions on equity interests in Holdco Nuvo Group D.G Ltd. and its affiliates, following a court ruling.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 6:40 am

BTCUSD

Senator Cynthia Lummis believes a Trump presidency would significantly benefit the cryptocurrency industry, advocating for a Bitcoin strategic reserve. In contrast, she predicts challenges if Kamala Harris wins. Lummis' proposed legislation aims to use Bitcoin to address the U.S. national debt.

Portfolio Pulse from Aniket Verma

September 05, 2024 | 4:17 am

NVDA

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin surged, diverging from the declining stock market. Bitcoin's price rose to $58,000 but remained volatile. Ethereum showed potential for further gains if it maintains above $2,400. Nvidia's stock fell amid DOJ subpoena rumors.

Portfolio Pulse from Aniket Verma

September 05, 2024 | 2:16 am

MSFT

Microsoft has avoided a UK antitrust investigation into its acquisition of certain assets from Inflection AI. The UK's Competition and Markets Authority (CMA) determined that the acquisition does not substantially lessen competition. Microsoft has recruited several key employees from Inflection AI, including Mustafa Suleyman, to strengthen its AI division.

Portfolio Pulse from Ananya Gairola

September 05, 2024 | 2:09 am

ADN

Advent Technologies received a Nasdaq notification for non-compliance with listing requirements but has been granted an extension to file delinquent reports by October 14, 2024. The company is working to regain compliance and has appointed three new board members.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:05 pm

PW

Power REIT has received a written notice from NYSE Regulation regarding its non-compliance with listing standards. This could impact its stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 9:21 pm

MODD

Modular Medical has received FDA clearance for its MODD1 insulin pump, a patch pump designed for adults with Type 1 and Type 2 diabetes. The device aims to be simpler and more affordable, targeting underserved communities. Commercial availability is expected in early 2025.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:40 pm

DNA

Ginkgo Bioworks has regained compliance with the New York Stock Exchange's listing standards, which is a positive development for the company.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:33 pm

SHPH

Shuttle Pharma has opened enrollment for a Phase 2 clinical trial of Ropidoxuridine for glioblastoma at two sites. The company received FDA Orphan Drug Designation for the drug and regained Nasdaq compliance after filing delayed financial reports.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 8:29 pm